NCT04989231View on ClinicalTrials.gov

An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

September 9, 2021

Primary Completion Date

December 25, 2022

Study Completion Date

December 25, 2022

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Investigational sIPV

Three intramuscular injections of the investigational vaccine (0.5 ml) at 0 month ,1 month and 2 months respectively; Single intramuscular injection of the investigational vaccine (0.5 ml) at 18 months

BIOLOGICAL

Control IPV

Three intramuscular injections of the control vaccine (0.5 ml) at 0 month ,1 month and 2 months respectively;Single intramuscular injection of the control vaccine (0.5ml) at 18 months

Trial Locations (1)

210009

Pizhou county Center for Disease Control and Prevention, Pizhou

All Listed Sponsors
lead

Sinovac Biotech Co., Ltd

INDUSTRY

NCT04989231 - An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses | Biotech Hunter | Biotech Hunter